C57BL/6 mice genetically deficient in interleukin 15 (IL-15−/− mice) were generated by gene targeting. IL-15−/− mice displayed marked reductions in numbers of thymic and peripheral natural killer (NK) T cells, memory phenotype CD8+ T cells, and distinct subpopulations of intestinal intraepithelial lymphocytes (IELs). The reduction but not absence of these populations in IL-15−/− mice likely reflects an important role for IL-15 for expansion and/or survival of these cells. IL-15−/− mice lacked NK cells, as assessed by both immunophenotyping and functional criteria, indicating an obligate role for IL-15 in the development and functional maturation of NK cells. Specific defects associated with IL-15 deficiency were reversed by in vivo administration of exogenous IL-15. Despite their immunological defects, IL-15−/− mice remained healthy when maintained under specific pathogen-free conditions. However, IL-15−/− mice are likely to have compromised host defense responses to various pathogens, as they were unable to mount a protective response to challenge with vaccinia virus. These data reveal critical roles for IL-15 in the development of specific lymphoid lineages. Moreover, the ability to rescue lymphoid defects in IL-15−/− mice by IL-15 administration represents a powerful means by which to further elucidate the biological roles of this cytokine.
Skip Nav Destination
Article navigation
6 March 2000
Article Contents
Article|
February 28 2000
Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice
Mary K. Kennedy,
Mary K. Kennedy
aImmunex Corporation, Seattle, Washington 98101
Search for other works by this author on:
Moira Glaccum,
Moira Glaccum
aImmunex Corporation, Seattle, Washington 98101
Search for other works by this author on:
Sandra N. Brown,
Sandra N. Brown
aImmunex Corporation, Seattle, Washington 98101
Search for other works by this author on:
Eric A. Butz,
Eric A. Butz
aImmunex Corporation, Seattle, Washington 98101
Search for other works by this author on:
Joanne L. Viney,
Joanne L. Viney
aImmunex Corporation, Seattle, Washington 98101
Search for other works by this author on:
Monica Embers,
Monica Embers
bPennsylvania State University College of Medicine, Hershey, Pennsylvania 17033
Search for other works by this author on:
Naoto Matsuki,
Naoto Matsuki
bPennsylvania State University College of Medicine, Hershey, Pennsylvania 17033
Search for other works by this author on:
Keith Charrier,
Keith Charrier
aImmunex Corporation, Seattle, Washington 98101
Search for other works by this author on:
Lisa Sedger,
Lisa Sedger
aImmunex Corporation, Seattle, Washington 98101
Search for other works by this author on:
Cynthia R. Willis,
Cynthia R. Willis
aImmunex Corporation, Seattle, Washington 98101
Search for other works by this author on:
Kenneth Brasel,
Kenneth Brasel
aImmunex Corporation, Seattle, Washington 98101
Search for other works by this author on:
Philip J. Morrissey,
Philip J. Morrissey
aImmunex Corporation, Seattle, Washington 98101
Search for other works by this author on:
Kim Stocking,
Kim Stocking
aImmunex Corporation, Seattle, Washington 98101
Search for other works by this author on:
JoAnn C. L. Schuh,
JoAnn C. L. Schuh
aImmunex Corporation, Seattle, Washington 98101
Search for other works by this author on:
Sebastian Joyce,
Sebastian Joyce
bPennsylvania State University College of Medicine, Hershey, Pennsylvania 17033
Search for other works by this author on:
Jacques J. Peschon
Jacques J. Peschon
aImmunex Corporation, Seattle, Washington 98101
Search for other works by this author on:
Mary K. Kennedy
aImmunex Corporation, Seattle, Washington 98101
Moira Glaccum
aImmunex Corporation, Seattle, Washington 98101
Sandra N. Brown
aImmunex Corporation, Seattle, Washington 98101
Eric A. Butz
aImmunex Corporation, Seattle, Washington 98101
Joanne L. Viney
aImmunex Corporation, Seattle, Washington 98101
Monica Embers
bPennsylvania State University College of Medicine, Hershey, Pennsylvania 17033
Naoto Matsuki
bPennsylvania State University College of Medicine, Hershey, Pennsylvania 17033
Keith Charrier
aImmunex Corporation, Seattle, Washington 98101
Lisa Sedger
aImmunex Corporation, Seattle, Washington 98101
Cynthia R. Willis
aImmunex Corporation, Seattle, Washington 98101
Kenneth Brasel
aImmunex Corporation, Seattle, Washington 98101
Philip J. Morrissey
aImmunex Corporation, Seattle, Washington 98101
Kim Stocking
aImmunex Corporation, Seattle, Washington 98101
JoAnn C. L. Schuh
aImmunex Corporation, Seattle, Washington 98101
Sebastian Joyce
bPennsylvania State University College of Medicine, Hershey, Pennsylvania 17033
Jacques J. Peschon
aImmunex Corporation, Seattle, Washington 98101
Abbreviations used in this paper: ES, embryonic stem; IEL, intestinal intraepithelial lymphocyte; polyI:C, polyinosilic-polycytidylic acid.
Received:
November 05 1999
Revision Requested:
December 22 1999
Accepted:
December 23 1999
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2000 The Rockefeller University Press
2000
The Rockefeller University Press
J Exp Med (2000) 191 (5): 771–780.
Article history
Received:
November 05 1999
Revision Requested:
December 22 1999
Accepted:
December 23 1999
Citation
Mary K. Kennedy, Moira Glaccum, Sandra N. Brown, Eric A. Butz, Joanne L. Viney, Monica Embers, Naoto Matsuki, Keith Charrier, Lisa Sedger, Cynthia R. Willis, Kenneth Brasel, Philip J. Morrissey, Kim Stocking, JoAnn C. L. Schuh, Sebastian Joyce, Jacques J. Peschon; Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice. J Exp Med 6 March 2000; 191 (5): 771–780. doi: https://doi.org/10.1084/jem.191.5.771
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement